XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.2
Balance Sheet Details (Tables)
6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory

Inventory consisted of the following (in thousands):

 

 

 

June 30,
2022

 

 

December 31,
2021

 

Finished goods

 

$

2,081

 

 

$

1,114

 

Work in process

 

 

4,246

 

 

 

6,767

 

Raw material

 

 

6,205

 

 

 

6,217

 

 

 

$

12,532

 

 

$

14,098

 

Reported as:

 

 

 

 

 

 

    Inventory

 

$

6,327

 

 

$

7,881

 

    Long-term inventory

 

 

6,205

 

 

 

6,217

 

    Total

 

$

12,532

 

 

$

14,098

 

Schedule of Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

 

 

 

June 30,
2022

 

 

December 31,
2021

 

Accrued research and development services

 

$

39,767

 

 

$

27,270

 

Accrued compensation and benefits

 

 

23,351

 

 

 

25,896

 

Accrued sales allowances

 

 

14,237

 

 

 

15,717

 

Accrued consulting and professional fees

 

 

11,441

 

 

 

9,319

 

Current portion of lease liabilities

 

 

9,024

 

 

 

8,304

 

Current portion of accrued branded prescription drug fees

 

 

7,021

 

 

 

1,959

 

Other

 

 

986

 

 

 

727

 

 

 

$

105,827

 

 

$

89,192